SC 14F1

SCHEDULE 14F-1 INFORMATION STATEMENT

Company: Actinium Pharmaceuticals, Inc.
Filed: January 3, 2013
Accession Number: 0001078782-13-000013

View Document ↗ View on SEC.gov ↗